Huntington National Bank’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-513
Closed -$23K 2070
2020
Q2
$23K Sell
513
-36
-7% -$1.61K ﹤0.01% 991
2020
Q1
$21K Sell
549
-7
-1% -$322 ﹤0.01% 1023
2019
Q4
$26K Sell
556
-80
-13% -$3.46K ﹤0.01% 1169
2019
Q3
$26K Sell
636
-45
-7% -$1.94K ﹤0.01% 1043
2019
Q2
$33K Buy
681
+1
+0.1% +$53 ﹤0.01% 989
2019
Q1
$43K Buy
680
+178
+35% +$12.2K ﹤0.01% 896
2018
Q4
$30K Sell
502
-343
-41% -$20.6K ﹤0.01% 1014
2018
Q3
$54K Sell
845
-66
-7% -$3.68K ﹤0.01% 939
2018
Q2
$41K Sell
911
-430
-32% -$17.1K ﹤0.01% 1028
2018
Q1
$42K Buy
1,341
+322
+32% +$10.6K ﹤0.01% 1016
2017
Q4
$30K Hold
1,019
﹤0.01% 1117
2017
Q3
$34K Buy
+1,019
New +$35.3K ﹤0.01% 1079
2015
Q1
Sell
-3,772
Closed -$38K 1843
2014
Q4
$38K Buy
+3,772
New +$32.3K ﹤0.01% 1190
2014
Q1
Sell
-7,382
Closed -$59K 1831
2013
Q4
$59K Buy
7,382
+2,887
+64% +$26.9K ﹤0.01% 1051
2013
Q3
$45K Buy
+4,495
New +$35.4K ﹤0.01% 1103

Other funds holding BEAT

Huntington National Bank's BEAT Position: Q3 2020 in Review

Huntington National Bank sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 513 shares — an estimated $23K sold.

Huntington National Bank first reported a position in BEAT in Q3 2013 and held it in 15 quarters. The position peaked at $59K in Q4 2013. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Huntington National Bank reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Huntington National Bank sold 513 BioTelemetry, Inc. shares in Q3 2020, an estimated $23K.
  • Huntington National Bank first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 15 quarters.
  • Huntington National Bank's BioTelemetry, Inc. position peaked at $59K in Q4 2013.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Huntington National Bank's 13F filing for Q3 2020, filed 30 Oct 2020.